Delta-Fly Pharma News

Delta-Fly Pharma: Independent Company Executives Declaration

Jun 27 02:00 ET

Delta-Fly Pharma: Matters related to business plans and growth potential.

Jun 21 02:00 ET

Delta-Fly Pharma: Announcements of the development of DFP-17729.

Jun 19 02:00 ET

DELTA FLY PHARMA: Notice regarding responses to inquiries

May 17 02:30 ET

Delta-Fly Pharma: Notice regarding permission to conduct clinical phase 1/2 trials of DFP-10917 and VTX

Apr 8 02:00 ET

Delta-Fly Pharma: Notice Concerning FDA Submission of Clinical Phase 1 and 2 Trial Protocols for DFP-10917 and VTX

Mar 11 02:00 ET

Delta-Fly Pharma: Notice regarding submission of abstracts relating to the DFP-14927 clinical phase 1 trial to ASCO

Feb 7 01:00 ET

Delta-Fly Pharma: Notice regarding the commencement of clinical phase 3 comparative trials of DFP-14323

Feb 2 01:00 ET

Delta-Fly Pharma: Notice regarding the interim analysis status of the DFP-10917 clinical phase 3 comparative trial

Jan 30 01:00 ET

Delta-Fly Pharma: 2024 New Year's Greetings from the President (Notice regarding DFP-10917 and DFP14927)

Jan 5 01:00 ET

Delta-Fly Pharma: Stock Transfer Report Affirmations Related to Third-Party Allocation (New Shares)

Nov 27, 2023 22:25 ET

Delta-Fly Pharma: Notice regarding DFP-10917 ASH (American Society of Hematology)

Nov 22, 2023 01:00 ET

Delta-Fly Pharma: Notice Concerning Mass Exercise of 7th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)

Nov 13, 2023 03:00 ET

Delta-Fly Pharma: Notice regarding publication in the American business magazine “Newly”

Sep 20, 2023 04:00 ET

Delta-Fly Pharma: Notice Concerning Interim Analysis Efforts for DFP-10917 Clinical Phase 3 Comparative Trials

Jun 30, 2023 02:00 ET

Delta-Fly Pharma: Independent Officer Notification Form

Jun 26, 2023 05:40 ET

Delta-Fly Pharma: Disclosure of matters relating to business plans and growth potential

Jun 26, 2023 04:40 ET

Delta-Fly Pharma: Notice regarding DFP-10917 clinical phase 3 comparative trial data analysis etc. and future plans

Jun 2, 2023 02:00 ET

Delta-Fly Pharma: Notice regarding completion of case registration for the clinical phase 3 comparative trial of DFP-10917

May 15, 2023 02:05 ET

Delta-Fly Pharma: Notice regarding case registration status of DFP-10917 clinical phase 3 controlled trial

Mar 31, 2023 02:00 ET